These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6240981)

  • 1. Inhibition of glucokinase in hepatocytes by alloxan.
    Miwa I; Hara H; Matsunaga H; Okuda J
    Biochem Int; 1984 Nov; 9(5):595-602. PubMed ID: 6240981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzyme.
    Lenzen S; Freytag S; Panten U
    Mol Pharmacol; 1988 Sep; 34(3):395-400. PubMed ID: 3419426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tumour necrosis factor-alpha on the enzymatic activities related to glucose metabolism.
    López-Soriano J; Argilés JM; López-Soriano FJ
    Biochem Mol Biol Int; 1993 May; 30(1):21-7. PubMed ID: 8358332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of glucokinase as an alloxan-sensitive glucose sensor of the pancreatic beta-cell.
    Meglasson MD; Burch PT; Berner DK; Najafi H; Matschinsky FM
    Diabetes; 1986 Oct; 35(10):1163-73. PubMed ID: 3530846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucokinase in pancreatic B-cells and its inhibition by alloxan.
    Lenzen S; Tiedge M; Panten U
    Acta Endocrinol (Copenh); 1987 May; 115(1):21-9. PubMed ID: 3296598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bordetella pertussis extract induces increase in the activities of glycolytic enzymes in mouse liver.
    Shyamala S; Sengupta SR; Ramakrishnan P
    Indian J Biochem Biophys; 1992 Oct; 29(5):445-7. PubMed ID: 1289237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of saccharol glycosides on energy metabolism in animals with abnormal carbohydrate tolerance].
    Smoliar Vi; Tsapko EV; Karpilovskaia ED; Pliss MB; Saliĭ NS; Grigorenko SN
    Vopr Pitan; 1993; (1):38-40. PubMed ID: 7975408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannitol 1-phosphate mediates an inhibitory effect of mannitol on the activity and the translocation of glucokinase in isolated rat hepatocytes.
    Niculescu L; Van Schaftingen E
    Diabetologia; 1998 Aug; 41(8):947-54. PubMed ID: 9726598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium's effects on rat liver glucose metabolism in vivo.
    Rodriguez-Gil JE; Fernández-Novell JM; Barberá A; Guinovart JJ
    Arch Biochem Biophys; 2000 Mar; 375(2):377-84. PubMed ID: 10700396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundamental metabolic differences between hepatocytes and islet beta-cells revealed by glucokinase overexpression.
    Berman HK; Newgard CB
    Biochemistry; 1998 Mar; 37(13):4543-52. PubMed ID: 9521775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor counteracts insulin-induced expression of glucokinase in hepatocytes.
    Beresford GW; Agius L
    Biochem Biophys Res Commun; 1994 Jun; 201(2):902-8. PubMed ID: 8003030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase.
    Tiedge M; Richter T; Lenzen S
    Arch Biochem Biophys; 2000 Mar; 375(2):251-60. PubMed ID: 10700381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements of alloxan and ninhydrin for glucokinase inhibition and of glucose for protection against inhibition.
    Lenzen S; Brand FH; Panten U
    Br J Pharmacol; 1988 Nov; 95(3):851-9. PubMed ID: 3207996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alloxan on the islets of Langerhans. Possible mechanisms of diabetogenic action.
    Borg LA
    Acta Biol Med Ger; 1981; 40(1):71-6. PubMed ID: 7020307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by the sulfonylurea glimepiride.
    Müller G; Korndörfer A; Kornak U; Malaisse WJ
    Arch Biochem Biophys; 1994 Jan; 308(1):8-23. PubMed ID: 8311478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomeric specificity of human liver and B-cell glucokinase: modulation by the glucokinase regulatory protein.
    Courtois P; Bource F; Sener A; Malaisse WJ
    Arch Biochem Biophys; 2000 Jan; 373(1):126-34. PubMed ID: 10620331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-chain fatty acyl-coenzyme A-induced inhibition of glucokinase in pancreatic islets from rats depleted in long-chain polyunsaturated omega3 fatty acids.
    Zhang Y; Bulur N; Peltier S; Carpentier YA; Malaisse WJ; Sener A
    Cell Biochem Funct; 2008; 26(2):233-7. PubMed ID: 17708576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a beta3-adrenergic agonist on liver glucokinase gene expression in alloxan-diabetic rats.
    Milagro FI; Gómez-Ambrosi J; Martínez-Ansó E; Martínez JA
    J Physiol Biochem; 1999 Mar; 55(1):25-31. PubMed ID: 10494657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of aconitase by alloxan and the differential modes of protection of glucose, 3-O-methylglucose, and mannoheptulose.
    Lenzen S; Mirzaie-Petri M
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):532-6. PubMed ID: 1470224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.